HEADER SURFACE ACTIVE PROTEIN 22-JUN-05 2A2H OBSLTE 10-APR-07 2A2H 2JOU TITLE NMR STRUCTURE OF MINI-B, AN N-TERMINAL- C-TERMINAL TITLE 2 CONSTRUCT FROM SURFACTANT PROTEIN B (SP-B), IN TITLE 3 HEXAFLUOROISOPROPANOL (HFIP) COMPND MOL_ID: 1; COMPND 2 MOLECULE: PULMONARY SURFACTANT-ASSOCIATED PROTEIN B; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: MINI-B; COMPND 5 SYNONYM: SP-B, 6 KDA PROTEIN, PULMONARY SURFACTANT- COMPND 6 ASSOCIATED PROTEOLIPID SPLPHE, 18 KDA PULMONARY-SURFACTANT COMPND 7 PROTEIN; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: THIS SEQUENCE IS A BIOLOGICALLY ACTIVE SOURCE 4 FRAGMENT (N- AND C-TERMINAL) OF THE NATURALLY OCCURING SOURCE 5 HUMAN PROTEIN, SP-B. KEYWDS MINI-B, SP-B, SURFACTANT PROTEIN B, LIPID ASSOCIATED PROTEIN EXPDTA NMR, 15 STRUCTURES AUTHOR V.BOOTH,M.SARKER,K.M.W.KEOUGH,A.J.WARING,F.J.WALTHER REVDAT 2 10-APR-07 2A2H 1 OBSLTE REVDAT 1 13-JUN-06 2A2H 0 JRNL AUTH V.BOOTH,M.SARKER,K.M.W.KEOUGH,A.J.WARING, JRNL AUTH 2 F.J.WALTHER JRNL TITL NMR STRUCTURE OF MINI-B, AN N-TERMINAL - JRNL TITL 2 C-TERMINAL CONSTRUCT FROM SURFACTANT PROTEIN B JRNL TITL 3 (SP-B), IN HEXAFLUOROISOPROPANOL (HFIP) JRNL REF TO BE PUBLISHED JRNL REFN REMARK 1 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2A2H COMPLIES WITH FORMAT V. 3.0, 1-DEC-2006 REMARK 4 REMARK 4 THIS FILE IS A TEST VERSION. REMARK 4 REMARK 4 THIS IS THE REMEDIATED VERSION OF THIS PDB ENTRY. REMARK 4 REMEDIATED DATA FILE REVISION 3.101 (2007-04-09) REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-JUL-2005. REMARK 100 THE RCSB ID CODE IS RCSB033408. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 288 REMARK 210 PH : 5 REMARK 210 IONIC STRENGTH : 0 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : PARTIALLY 15N LABELLED WITH REMARK 210 15N LABELS ON LEUCINE (3, 7, REMARK 210 22, 25, 29, 31), ALANINE (6, REMARK 210 13) AND GLYCINE (18); 1.5MM REMARK 210 PEPTIDE, 0.4MM DSS, 40% HFIP, REMARK 210 50% H2O, 10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D NOESY, 2D TOCSY, 3D_15N- REMARK 210 SEPARATED_NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 700 MHZ, 500 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE 2.2, SPARKY 3.110, REMARK 210 MOLMOL 2K.2 REMARK 210 METHOD USED : SIMULATED ANNEALING; REMARK 210 MOLECULAR DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 15 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES: ENGH AND HUBER, 1991 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 8 LEU A 22 N - CA - C ANGL. DEV. = 6.3 DEGREES REMARK 500 10 ARG A 32 N - CA - C ANGL. DEV. = 6.0 DEGREES REMARK 500 13 MET A 21 N - CA - C ANGL. DEV. = 7.3 DEGREES REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 5 ARG A 20 82.38 146.10 REMARK 500 5 LEU A 22 61.96 -0.34 REMARK 500 8 ARG A 20 77.98 145.45 REMARK 500 9 LEU A 22 129.68 91.68 REMARK 500 11 ARG A 20 85.15 102.48 REMARK 500 12 ARG A 20 66.20 148.93 REMARK 500 13 ARG A 20 78.83 125.17 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1RG3 RELATED DB: PDB REMARK 900 THIS PEPTIDE CONSISTS OF THE C-TERMINAL HALF OF MINI-B. REMARK 900 THIS STRUCTURE WAS DETERMINED IN SDS MICELLES. REMARK 900 RELATED ID: 1RG4 RELATED DB: PDB REMARK 900 THIS PEPTIDE CONSISTS OF THE C-TERMINAL HALF OF MINI-B. REMARK 900 THIS STRUCTURE WAS DETERMINED IN HFIP. DBREF 2A2H A 1 18 UNP P07988 PSPB_HUMAN 208 225 DBREF 2A2H A 19 34 UNP P07988 PSPB_HUMAN 263 278 SEQRES 1 A 34 CYS TRP LEU CYS ARG ALA LEU ILE LYS ARG ILE GLN ALA SEQRES 2 A 34 MET ILE PRO LYS GLY GLY ARG MET LEU PRO GLN LEU VAL SEQRES 3 A 34 CYS ARG LEU VAL LEU ARG CYS SER HELIX 1 1 TRP A 2 ILE A 15 1 14 HELIX 2 2 PRO A 23 CYS A 33 1 11 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1